Traders Purchase Large Volume of Allscripts Healthcare Solutions Call Options (NASDAQ:MDRX)

Lloyd Doyle
January 13, 2018

The stock decreased 2.76% or $0.43 during the last trading session, reaching $15.17. About 707,168 shares traded. After having $0.12 EPS previously, Allscripts Healthcare Solutions, Inc.'s analysts see 8.33% EPS growth. (NASDAQ:MDRX) has declined 8.32% since January 11, 2017 and is downtrending. It was reported on Jan, 10 by Barchart.com. (NASDAQ:MDRX) on Friday, September 15. Fiduciary Management Inc. WI now owns 6,083,536 shares of the software maker's stock valued at $77,626,000 after buying an additional 38,426 shares in the last quarter. The Aegis Financial Corp holds 65,678 shares with $1.00 million value, down from 219,814 last quarter. Haemonetics Corp now has $3.40B valuation.

The stock increased 3.11% or $0.47 during the last trading session, reaching $15.56. MDRX trades with a P/S ratio of 1.68. The Gabelli Healthcare & Wellness Trust (GRX) has risen 1.37% since January 12, 2017 and is uptrending. It has outperformed by 16.36% the S&P500.

Investors sentiment decreased to 1.16 in Q3 2017. 7,118 shares were sold by KROLL MARK W, worth $448,434 on Tuesday, January 2. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. Therefore 40% are positive. They set a "neutral" rating for the company. The firm has "Overweight" rating given on Friday, October 28 by JP Morgan. The rating was upgraded by Sidoti on Tuesday, August 4 to "Buy". (NASDAQ:MDRX) has "Buy" rating given on Friday, January 22 by Argus Research. (NASDAQ:MDRX) has "Hold" rating given on Wednesday, August 5 by Topeka Capital Markets.

In related news, EVP Brian Farley sold 5,000 shares of the firm's stock in a transaction that occurred on Thursday, December 14th. The stock has "Hold" rating by Deutsche Bank on Thursday, November 10.

683 Capital Management Llc, which manages about $566.08 million and $951.63M US Long portfolio, upped its stake in Altaba Inc by 25,000 shares to 325,000 shares, valued at $21.53 million in 2017Q3, according to the filing. The NYSE-listed company saw a recent bid of $42.42 on volume of 1.95 million shares. Campbell Soup Co (NYSE:CPB) was reduced too. Its down 0.29, from 1.45 in 2017Q2. It dropped, as 22 investors sold MDRX shares while 72 reduced holdings. 33 funds opened positions while 64 raised stakes. Tcw Gru owns 10,184 shares for 0% of their portfolio. Monarch Asset Mngmt Lc reported 453,080 shares. The stock has a consensus rating of "Buy" and an average price target of $15.06. (NASDAQ:MDRX). Ancora Ltd Liability Corp holds 0.23% or 279,321 shares in its portfolio. It is calculated by multiplying a company's shares outstanding by the current market price of one share. Great Lakes Advsrs Limited Company reported 491,817 shares. The New York-based First Manhattan Co has invested 0.03% in the stock. Louisiana State Employees Retirement Systems has invested 0.04% in Haemonetics Corporation (NYSE:HAE). Dimensional Fund Advisors LP increased its stake in shares of Allscripts Healthcare Solutions by 26.9% during the 2nd quarter. Ww Asset Management holds 11,565 shares. Ameriprise Fincl reported 578,717 shares stake. 55,847 were accumulated by Piermont Mgmt Incorporated. Blue Harbour Group L.P., a Connecticut-based fund reported 3.87 million shares. First Quadrant L P Ca holds 62,300 shares or 0.02% of its portfolio. Finally, Vanguard Group Inc. increased its stake in shares of Allscripts Healthcare Solutions by 1.2% during the 2nd quarter. Black Paul sold 15,000 shares worth $202,800. After $-0.40 actual EPS reported by uniQure N.V. for the previous quarter, Wall Street now forecasts 80.00% negative EPS growth. In the last three months, insiders have sold 56,796 shares of company stock valued at $804,842. Citigroup assumed coverage on shares of Allscripts Healthcare Solutions in a research report on Thursday, January 4th. (NASDAQ:MDRX) to report earnings on February, 15. MDRX's profit would be $23.49 million giving it 30.79 P/E if the $0.13 EPS is correct. MDRX's profit will be $23.48 million for 30.71 P/E if the $0.13 EPS becomes a reality. Tudor Inv Et Al holds 0.02% of its portfolio in Allscripts Healthcare Solutions, Inc.


Investors who took positions in shares of Allscripts Healthcare Solutions, Inc. The firm's market capitalization is $2.13 billion. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. On average, analysts predict that Allscripts Healthcare Solutions, Inc. will post $0.57 earnings per share for the current fiscal year.

Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) have been assigned a consensus recommendation of "Buy" from the twenty brokerages that are now covering the stock, MarketBeat Ratings reports. Therefore 46% are positive. MDRX was included in 7 notes of analysts from August 5, 2015. Jefferies has "Buy" rating and $16.5 target. The stock has "Outperform" rating by Cowen & Co on Monday, September 11. The rating was downgraded by Morgan Stanley on Tuesday, December 13 to "Underweight". Canaccord Genuity initiated the stock with "Buy" rating in Wednesday, September 16 report. As per Tuesday, October 17, the company rating was maintained by Robert W. Baird.

ILLEGAL ACTIVITY NOTICE: "Allscripts Healthcare Solutions' (MDRX) "Buy" Rating Reiterated at Cantor Fitzgerald" was published by Week Herald and is the sole property of of Week Herald. RBC Capital Markets maintained it with "Outperform" rating and $17 target in Friday, February 19 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER